Clinical Trial Update: Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates consolidation of first-line MRD-positive remission with Cema-cel in patients with Large B-cell lymphoma, with the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• Cema-cel

Snippet

Sponsor: Allogene Therapeutics | Conditions: Large B-cell Lymphoma | Phase 2 | Status: RECRUITING